Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Cerevel Therapeutics Holdings, Inc. Common Stock | CERE

Daily Technical Analysis of Cerevel Therapeutics Holdings, Inc. Common Stock

Not too much action today, Cerevel Therapeutics Holdings drifted down slightly. We'll see where it goes next.

The Food & Beverage company isn't at an immediate support or resistance level that might be predictive. Cerevel Therapeutics Holdings has looked pretty good over the last few months. It has definitely cuaght a bid and had a nice run. Over the last 3 months, shareholders are up 2.33 percent. CERE might find some support at the 32.42 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-03-17

Analyst Ratings for Cerevel Therapeutics Holdings By Price Target And Rating

The analysts are pretty neutral on Cerevel Therapeutics Holdings right now, so not much useful information here. The current Analysts Sentiment Score is -3.09. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Mizuho gave a boost to their price target and moved to $45.00 from $25.00 on 2024-02-16. JPMorgan Chase & Co. provided a price target boost of 80% to $45.00 from $25.00 on 2023-12-28. Jefferies Financial Group reiterated a rating of Buy on 2023-12-22 and also increased their price target by 12.5% to $45.00. TD Cowen reiterated a rating of Outperform on 2023-12-08 and added a price target of $45.00. Piper Sandler reiterated a rating of Overweight on 2023-12-07 and moved up their price target to $45.00 which is a 36.36% increase. On 2023-12-07 HC Wainwright downgraded Cerevel Therapeutics Holdings from Buy to Neutral but moved up their price target to $45.00 which is a 9.76% increase. Cantor Fitzgerald released a downgrade on 2023-12-07 from Overweight to Neutral but provided a price target boost 18.42% to $45.00 from $38.00. Morgan Stanley announced a lowering of their price target to $38.00 from $42.00 on 2023-11-02. Bank of America released a downgrade on 2023-08-03 from Buy to Neutral and decided to decrease their price target by -13.89% down to $31.00. On 2023-05-04 Wells Fargo & Company upgraded Cerevel Therapeutics Holdings from Equal Weight to Overweight and they set their price target at $30.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
CERE-3.091.77-106.42102.76-4.28

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-04-08)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
CERE0.000.00

Short interest for Cerevel Therapeutics Holdings

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
CERE10.57%10.48.420.5927410000

How Cerevel Therapeutics Holdings compares to the broader Consumer Goods sector and the more specific Food & Beverage industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Food & Beverage

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
1-0.191.331.092.3380.2537.9895.00123.6935.4432.89-538.22-72585.81100.000.0010.57-3.09
Consumer Goods

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
1-0.191.331.092.3380.2537.9895.00123.6935.4432.89-538.22-72585.81100.000.0010.57-3.09

Social Sentiment for Cerevel Therapeutics Holdings

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
CERE

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-